CPI-0209
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CPI-0209, covering 2025-06-19 to 2025-06-19. Get the full timeline:
Most recent: Clinical Trial Update: CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer [Phase 1]